Singapore / MyNewsDesk / Novus Scientific Pte. Ltd today announced that TIGR® Matrix Surgical Mesh, the World’s 1st Long-Term Resorbable Synthetic Mesh will be launched at APHS 2011 (www.aphs2011.org/) in Hua Hin, Thailand, from November 9th – 11th, 2011.

This event has been postponed to Jan 11-13, 2012, due to the floods in Thailand.

To mark this occasion, Professor Stellan Björk, Principal Investigator and Consultant Surgeon at Sahlgrenska University Hospital, Gothenburg, Sweden, will lecture on “Results of the first-in-man trial of a new synthetic long-term resorbable surgical mesh” in the main scientific session. (http://www.aphs2011.org/schedule.php)

APHS 2011 marks an important milestone for TIGR® Matrix and Novus Scientific as we are able to finally meet the demand from Asian surgeons for a synthetic long-term resorbable mesh. Our plan is to expand registration of TIGR® Matrix  to a number of key markets in Asia, so we can offer TIGR® Matrix  to leading surgeons and hospitals across Asia”, said Thomas Engström, CEO & President of Novus Scientific.

“A number of renowned surgeons in Asia are already involved in a multicenter randomized controlled study using TIGR® Matrix . We are excited to be able to provide TIGR® Matrix  for their regular clinical practice soon”, said Tac-Whei Ong, VP Sales and Marketing, Asia Pacific.

TIGR® Matrix  is the World’s 1st Long-Term Resorbable Synthetic Mesh. US FDA cleared TIGR® Matrix  Surgical Mesh for use in reinforcement of soft tissues where weakness exists in January 2010. It received CE Mark approval in August 2011.

 

TIGR® Matrix  Surgical Mesh is available for sale in the U.S. and selected European countries.

 

About Novus Scientific (SHORT VERSION)

Novus Scientific (www.novusscientific.com) is an innovator in the development and commercialization of resorbable synthetic medical devices. For comprehensive information vist our PRESSROOM: http://www.mynewsdesk.com/pressroom/novus-scientific

 

TIGR® is a trademark of Novus Scientific Pte. Ltd

 

CONTACT:  
Tac-Whei Ong: +66-817 33 9524- tacwhei.ong@novusscientific.com

 

Comments are closed.

Select News Source

News by Date